The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

Endocrinology Month in Review: February 2025 | Image Credit: HCPLive
Endocrinology Month in Review: February 2025

March 6th 2025

This February 2025 month in review covers key updates in endocrinology, including the end to the semaglutide shortage and new automated insulin delivery data.

FDA Accepts NDA for Relacorilant for Endogenous Hypercortisolism | Image Credit: US Food and Drug Administration
FDA Accepts NDA for Relacorilant for Endogenous Hypercortisolism

March 3rd 2025

FDA News Month in Review: January 2025 | Image Credit: HCPLive
FDA News Month in Review: February 2025

February 28th 2025

FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy) | Image Credit: US Food and Drug Administration
FDA Announces End to Shortage of Semaglutide Products (Ozempic, Wegovy)

February 21st 2025

Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD | Image Credit: Mount Sinai
Sotagliflozin Cuts MACE Risk By 23% in Patients with Type 2 Diabetes, CKD

February 18th 2025

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.